Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Last modified by ircm doc
Group name EquipeLLC
Item Type Journal Article
Title Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53
Creator Riscal et al.
Author R. Riscal
Author E. Schrepfer
Author G. Arena
Author M. Y. Cisse
Author F. Bellvert
Author M. Heuillet
Author F. Rambow
Author E. Bonneil
Author F. Sabourdy
Author C. Vincent
Author I. Ait-Arsa
Author T. Levade
Author P. Thibaut
Author J. C. Marine
Author J. C. Portais
Author J. E. Sarry
Author L. Le Cam
Author L. K. Linares
Abstract The mouse double minute 2 (MDM2) oncoprotein is recognized as a major negative regulator of the p53 tumor suppressor, but growing evidence indicates that its oncogenic activities extend beyond p53. Here, we show that MDM2 is recruited to chromatin independently of p53 to regulate a transcriptional program implicated in amino acid metabolism and redox homeostasis. Identification of MDM2 target genes at the whole-genome level highlights an important role for ATF3/4 transcription factors in tethering MDM2 to chromatin. MDM2 recruitment to chromatin is a tightly regulated process that occurs during oxidative stress and serine/glycine deprivation and is modulated by the pyruvate kinase M2 (PKM2) metabolic enzyme. Depletion of endogenous MDM2 in p53-deficient cells impairs serine/glycine metabolism, the NAD+/NADH ratio, and glutathione (GSH) recycling, impacting their redox state and tumorigenic potential. Collectively, our data illustrate a previously unsuspected function of chromatin-bound MDM2 in cancer cell metabolism.
Publication Mol Cell
Date May 31 2016
Journal Abbr Molecular cell
DOI 10.1016/j.molcel.2016.04.033
ISSN 1097-4164 (Electronic) 1097-2765 (Linking)
Tags first-last-corresponding, original, top
Date Added 2018/11/14 - 11:59:48
Date Modified 2025/01/09 - 15:22:07
Notes and Attachments (Note)
(Note)
27264869 (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés